Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
5,478,126
-
Share change
-
+63,800
-
Total reported value
-
$30,127,000
-
Price per share
-
$5.50
-
Number of holders
-
36
-
Value change
-
+$352,689
-
Number of buys
-
12
-
Number of sells
-
14
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q4 2016
As of 31 Dec 2016,
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,478,126 shares.
The largest 10 holders included
ARIEL INVESTMENTS, LLC, DIMENSIONAL FUND ADVISORS LP, Stonepine Capital Management, LLC, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, NEW YORK STATE COMMON RETIREMENT FUND, BRIDGEWAY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, and BARD ASSOCIATES INC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.